Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

MK0686 in Postsurgery Dental Pain (0686-002)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier:
NCT00533403
First received: September 19, 2007
Last updated: May 8, 2014
Last verified: May 2014
  Purpose

To compare the pain relieving effect of MK0686 to placebo or ibuprofen after dental surgery.


Condition Intervention Phase
Pain, Postoperative
Drug: MK0686
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment

Further study details as provided by Merck Sharp & Dohme Corp.:

Study Start Date: June 2004
Study Completion Date: June 2004
  Eligibility

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Men and women ages 18-45 years who are scheduled to have 2 or more third molars (wisdom teeth) removed
  • Patients must agree to remain in the clinic for 24 hours after surgery

Exclusion Criteria:

  • Patient has history of heart disease, asthma, pulmonary disease
  • Patient must discontinue use of certain pain medicines 24-72 hours prior to the surgery
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00533403

Sponsors and Collaborators
Merck Sharp & Dohme Corp.
Investigators
Study Director: Medical Monitor Merck Sharp & Dohme Corp.
  More Information

No publications provided

Responsible Party: Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier: NCT00533403     History of Changes
Other Study ID Numbers: 0686-002, 2007_617
Study First Received: September 19, 2007
Last Updated: May 8, 2014
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Pain, Postoperative
Pain
Pathologic Processes
Postoperative Complications
Signs and Symptoms

ClinicalTrials.gov processed this record on November 27, 2014